Abstract
Cell-penetrating peptides (CPPs) are short peptides that can cross cell membranes. CPPs enable the delivery of biomolecules into cells and can act as drug-delivery vectors. Because recombinant production of CPPs as fusions to protein “cargo” leads to low yields for some CPP-cargo fusions, approaches to enhance the recombinant expression of peptide-cargo fusions need to be identified. We optimized expression conditions in Escherichia coli for fusions of CPPs (SynB, histatin-5, and MPG) to the cargo proteins biotin carboxyl carrier protein, maltose-binding protein, and green fluorescent protein. We used Western blotting to evaluate induction temperatures of 37, 30, and 20°C, and induction times of 6, 10, and 24 h. Glutathione-S-transferase was incorporated as a fusion partner to improve expression. In general, expression at 37°C for 6 and 10 h led to the highest levels of expression for the different CPP-cargo constructs. The improvements in expression of CPP-cargo fusions will allow higher yields of CPP-cargo fusions for studies of their translocation into cells.
Journal Section:
Research Article
References
1.
Albarran B, To R, Stayton PS: A TAT-streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells. Protein Eng Des Sel 2005; 18: 147–152.
2.
Alhakamy NA, Nigatu AS, Berkland CJ, Ramsey JD: Noncovalently associated cell-penetrating peptides for gene delivery applications. Ther Deliv 2013; 4: 741–757.
3.
Beloor J, Zeller S, Choi CS, Lee SK, Kumar P: Cationic cell-penetrating peptides as vehicles for siRNA delivery. Ther Deliv 2015; 6: 491–507.
4.
Chalfie M, Tu Y, Euskirchen G, Ward WW, Prasher DC: Green fluorescent protein as a marker for gene expression. Science 1994; 263: 802–805.
5.
Choi-Rhee E, Cronan JE: The biotin carboxylase-biotin carboxyl carrier protein complex of Escherichia coli acetyl-CoA carboxylase. J Biol Chem 2003; 278: 30806–30812.
6.
Copolovici DM, Langel K, Eriste E, Langel U: Cell-penetrating peptides: design, synthesis, and applications. ACS Nano 2014; 8: 1972–1994.
7.
Derossi D, Joliot AH, Chassaing G, Prochiantz A: The third helix of the antennapedia homeodomain translocates through biological membranes. J Biol Chem 1994; 269: 10444–10450.
8.
di Guan C, Li P, Riggs PD, Inouye H: Vectors that facilitate the expression and purification of foreign peptides in Escherichia coli by fusion to maltose-binding protein. Gene 1988; 67: 21–30.
9.
Drin G, Cottin S, Blanc E, Rees AR, Temsamani J: Studies on the internalization mechanism of cationic cell-penetrating peptides. J Biol Chem 2003; 278: 31192–31201.
10.
Du H, Puri S, McCall A, Norris HL, Russo T, Edgerton M: Human salivary protein histatin 5 has potent bactericidal activity against ESKAPE pathogens. Front Cell Infect Microbiol 2017; 7: 41.
11.
Esposito D, Chatterjee DK: Enhancement of soluble protein expression through the use of fusion tags. Curr Opin Biotechnol 2006; 17: 353–358.
12.
Frankel AD, Pabo CO: Cellular uptake of the TAT protein from human immunodeficiency virus. Cell 1988; 55: 1189–1193.
13.
Gong Z, Ikonomova SP, Karlsson AJ: Secondary structure of cell-penetrating peptides during interaction with fungal cells. Protein Sci 2018; 27: 702–713.
14.
Gong Z, Karlsson AJ: Translocation of cell-penetrating peptides into Candida fungal pathogens. Protein Sci 2017; 26: 1714–1725.
15.
Gong Z, Walls MT, Karley AN, Karlsson AJ: Effect of a flexible linker on recombinant expression of cell-penetrating peptide fusion proteins and their translocation into fungal cells. Mol Biotechnol 2016; 58: 838–849.
16.
Green M, Loewenstein PM: Autonomous functional domains of chemically synthesized human immunodeficiency virus TAT trans-activator protein. Cell 1988; 55: 1179–1188.
17.
Gupta B, Levchenko TS, Torchilin VP: Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv Drug Deliv Rev 2005; 57: 637–651.
18.
Helmerhorst EJ, Breeuwer P, van’t Hof W, Walgreen-Weterings E, Oomen LC, Veerman EC, Amerongen AV, Abee T: The cellular target of histatin 5 on Candida albicans is the energized mitochondrion. J Biol Chem 1999; 274: 7286–7291.
19.
Ilsen CYTZ, Onsan BK: Optimization of starting time and period of induction and inducer concentration in the production of the restriction enzyme EcoRI from recombinant E. coli. Turk J Chem 1998; 22: 221–226.
20.
Kapust RB, Waugh DS: Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Protein Sci 1999; 8: 1668–1674.
21.
Koren E, Torchilin VP: Cell-penetrating peptides: breaking through to the other side. Trends Mol Med 2012; 18: 385–393.
22.
Kristensen M, Birch D, Morck Nielsen H: Applications and challenges for use of cell-penetrating peptides as delivery vectors for peptide and protein cargos. Int J Mol Sci 2016; 17: 185.
23.
Lee CH, Chou CC, Hsu MF, Wang AH: Determining the N-terminal orientations of recombinant transmembrane proteins in the Escherichia coli plasma membrane. Sci Rep 2015; 5: 15086.
24.
Mae M, Langel U: Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery. Curr Opin Pharmacol 2006; 6: 509–514.
25.
Marini G, Luchese MD, Argondizzo AP, de Goes AC, Galler R, Alves TL, Medeiros MA, Larentis AL: Experimental design approach in recombinant protein expression: determining medium composition and induction conditions for expression of pneumolysin from Streptococcus pneumoniae in Escherichia coli and preliminary purification process. BMC Biotechnol 2014; 14: 1.
26.
Mochon AB, Liu H: The antimicrobial peptide histatin-5 causes a spatially restricted disruption on the Candida albicans surface, allowing rapid entry of the peptide into the cytoplasm. PLoS Pathog 2008; 4:e1000190.
27.
Morris MC, Deshayes S, Heitz F, Divita G: Cell-penetrating peptides: from molecular mechanisms to therapeutics. Biol Cell 2008; 100: 201–217.
28.
Morris MC, Vidal P, Chaloin L, Heitz F, Divita G: A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res 1997; 25: 2730–2736.
29.
Nallamsetty S, Austin BP, Penrose KJ, Waugh DS: Gateway vectors for the production of combinatorially-tagged His6-MBP fusion proteins in the cytoplasm and periplasm of Escherichia coli. Protein Sci 2005; 14: 2964–2971.
30.
Niwa H, Inouye S, Hirano T, Matsuno T, Kojima S, Kubota M, Ohashi M, Tsuji FI: Chemical nature of the light emitter of the Aequorea green fluorescent protein. Proc Natl Acad Sci USA 1996; 93: 13617–13622.
31.
Ormo M, Cubitt AB, Kallio K, Gross LA, Tsien RY, Remington SJ: Crystal structure of the Aequorea victoria green fluorescent protein. Science 1996; 273: 1392–1395.
32.
Puri S, Edgerton M: How does it kill? Understanding the candidacidal mechanism of salivary histatin 5. Eukaryot Cell 2014; 13: 958–964.
33.
Rajarao GK, Nekhotiaeva N, Good L: Peptide-mediated delivery of green fluorescent protein into yeasts and bacteria. FEMS Microbiol Lett 2002; 215: 267–272.
34.
Rajarao GK, Nekhotiaeva N, Good L: The signal peptide NPFSD fused to ricin A chain enhances cell uptake and cytotoxicity in Candida albicans. Biochem Biophys Res Commun 2003; 301: 529–534.
35.
Raran-Kurussi S, Waugh DS: The ability to enhance the solubility of its fusion partners is an intrinsic property of maltose-binding protein but their folding is either spontaneous or chaperone-mediated. PLoS One 2012; 7: e49589.
36.
Rosano GL, Ceccarelli EA: Recombinant protein expression in Escherichia coli: advances and challenges. Front Microbiol 2014; 5: 172.
37.
Sadler K, Eom KD, Yang JL, Dimitrova Y, Tam JP: Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7. Biochemistry 2002; 41: 14150–14157.
38.
Shin MC, Zhang J, Min KA, Lee K, Byun Y, David AE, He H, Yang VC: Cell-penetrating peptides: achievements and challenges in application for cancer treatment. J Biomed Mater Res A 2014; 102: 575–587.
39.
Smith DB: Generating fusions to glutathione S-transferase for protein studies. Methods Enzymol 2000; 326: 254–270.
40.
Smith DB, Johnson KS: Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 1988; 67: 31–40.
41.
SØrensen HP, Mortensen KK: Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli. Microb Cell Fact 2005; 4: 1.
42.
Tan PK, Howard JP, Payne GS: The sequence NPFXD defines a new class of endocytosis signal in Saccharomyces cerevisiae. J Cell Biol 1996; 135: 1789–1800.
43.
Temsamani J, Laruelle C: SynB peptide vectors: a new approach to drug delivery. Chimica Oggi 2010; 28: 18–20.
44.
Tsien RY: The green fluorescent protein. Annu Rev Biochem 1998; 67: 509–544.
45.
Xiang S, Tong L: Crystal structures of human and Staphylococcus aureus pyruvate carboxylase and molecular insights into the carboxyltransfer reaction. Nat Struct Mol Biol 2008; 15: 295–302.
46.
Yu K, Liu C, Kim BG, Lee DY: Synthetic fusion protein design and applications. Biotechnol Adv 2015; 33: 155–164.
47.
Zhang JH, Yun J, Shang ZG, Zhang XH, Pan BR: Design and optimization of a linker for fusion protein construction. Prog Nat Sci 2009; 19: 1197–1200.
© 2018 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2018
You do not currently have access to this content.
